Consultation and Research
Consultation and Research – Clinical Laboratory Affairs
bioMérieux values our commitment to Consultation and Research and is an important part of 360°/365° - New Dimensions in Support. Excellent customer service, timely education of technologists, and best in class products allow us to partner with you and ultimately enable a better patient experience and outcome. The Clinical Laboratory Affairs Department is made up of 2 functional areas: the Customer Response Lab (CRL) and the bioMérieux Organism Resistance Surveillance Network (BORIS). CRL and BORIS are primarily focused on the consultation and support of our Identification and Susceptibility products in partnership with our customers.
Customer Response Lab (CRL) In an effort to better support our customer base bioMérieux established the CRL. These scientists work with our customers through our Call Center Application Specialist or Field Technical Consultants. The contact is documented in our internal system. The organism or product in question is submitted to our laboratory in St. Louis where we evaluate / investigate the concern through lab testing and data analysis. We work with R&D, Manufacturing and other internal departments to evaluate our findings and report back to the customer.
The bioMérieux Organism Resistance Surveillance Network (BORIS) was established as a means for bioMérieux to actively participate in the epidemiologic surveillance of microorganisms exhibiting unusual patterns of resistance. BORIS works with several clinical laboratories located throughout the US to collect target organisms. These isolates are sent to our St. Louis laboratory for ID and AST confirmation, and additional testing. From these isolates, not only can we determine trends in antibiotic resistance and detect regional differences in antibiotic resistance expression, but also these isolates are available for subsequent research and development activity.
Partnering with our customers in this manner provides us an opportunity to work with fresh clinical isolates to challenge and enhance our current products and develop future products based upon the needs presented from the laboratory community.
ASM 2008 Presentations: